toggle visibility Search & Display Options

Select All    Deselect All
 |   | 
  Record Links
Author (up) Iversen, M.M.; Nefs, G.; Tell, G.S.; Espehaug, B.; Midthjell, K.; Graue, M.; Pouwer, F. url  doi
  Title Anxiety, depression and timing of insulin treatment among people with type 2 diabetes: Nine-year follow-up of the Nord-Trondelag Health Study, Norway Type Journal Article
  Year 2015 Publication J Psychosom Res Abbreviated Journal Journal of psychosomatic research  
  Volume 79 Issue 4 Pages 309-315  
  Keywords HUNT2; Adult; Aged; Aged, 80 and over; Anxiety/*etiology; Cohort Studies; Depression/diagnosis/*etiology; Diabetes Mellitus, Type 2/*complications/drug therapy; Female; Humans; Insulin/administration & dosage/*therapeutic use; Male; Middle Aged; Norway; Prospective Studies; Young Adult  
  Abstract BACKGROUND: Depression and anxiety have been found to be predictors of poor health outcomes in diabetes, but mechanisms are still unclear. AIMS: To examine whether symptoms of anxiety and depression were associated with timing of initiating insulin therapy. METHODS: A cohort study of insulin-naive particpants with type 2 dabetes completed the Hospital Anxiey and Depression Scale, HADS-A (n = 731) and/or the HADS-D (n = 768) in the communy-based Nord-Trondelag Health Study (1995-1997). Information on insulin initiation was retrieved from the Norwegian Prescription Database from January 1, 2004 to November 21, 2012. Cox regression analyses were used to estimate the association between symptoms of anxiety, depression and time to insulin initiation. RESULTS: At baseline, 19% reported anxiety symptoms (score>/=8) and 18% depressive symptoms (score>/=8). After a mean follow-up of 4.4 (SD 3.6) years, 337 (40%) participants had started insulin therapy. After adjustment for sociodemographic and clinical variables, anxiety symptoms were associated with later initiation of insulin therapy (HR 0.70, 95% CI 0.49-0.99), while depressive symptoms were not. Considering groups simultaneously, having both elevated depressive and elevated anxiety symptoms was associated with later time to insulin initiation (HR 0.62, 95% CI 0.39-0.99), while having only anxiety symptoms (without depressive) HR 0.81, 95% CI 0.50-1.32) or only depressive symptoms (without anxiety) (HR 1.08, 95% CI 0.68-1.72) were not. CONCLUSIONS: Anxiety was associated with a later initiation of insulin, while depressive symptoms were not. Persons with both elevated levels of anxiety and depression were also less likely to start insulin therapy. These results need further testing in other prospective studies.  
  Corporate Author Thesis  
  Publisher Place of Publication Centre for Evidence-Based Practice, Bergen University College, Norway; Department of Endocrinology, Editor  
  Language Summary Language Original Title  
  Series Editor Series Title Abbreviated Series Title  
  Series Volume Series Issue Edition  
  ISSN ISBN Medium  
  Area Expedition Conference  
  Notes Iversen, M MNefs, GTell, G SEspehaug, BMidthjell, KGraue, MPouwer, FengEngland2015/07/26 06:00J Psychosom Res. 2015 Oct;79(4):309-15. doi: 10.1016/j.jpsychores.2015.07.004. Epub 2015 Jul 16. Approved no  
  Call Number HUNT @ maria.stuifbergen @ Iversen2015b Serial 1825  
Permanent link to this record
Select All    Deselect All
 |   | 

Save Citations:
Export Records: